Andrea S. Fung

ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results

Valsamo Anagnostou, Cheryl Ho, Garth Nicholas et al. · Nature Medicine · 2023 · 150 citations · Full text

Medicine, Oncology, Pharmacology +17

Concurrent and Sequential Administration of Chemotherapy and the Mammalian Target of Rapamycin Inhibitor Temsirolimus in Human Cancer Cells and Xenografts

Andrea S. Fung, Licun Wu, Ian F. Tannock · Clinical Cancer Research · 2009 · 58 citations

Medicine, Oncology, Pharmacology +16

Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial

Marcin Dzienis, Juan Cundom, Christian Sebastian Fuentes et al. · Journal of Clinical Oncology · 2024 · 55 citations · Full text

Medicine, Oncology, Pharmacology +14

The effect of chemotherapeutic agents on tumor vasculature in subcutaneous and orthotopic human tumor xenografts

Andrea S. Fung, Carol Lee, Man Yu et al. · BMC Cancer · 2015 · 48 citations · Full text

Medicine, Oncology, Pharmacology +12

A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in Canada

A. Elegbede, A.J. Gibson, Andrea S. Fung et al. · JTO Clinical and Research Reports · 2021 · 34 citations · Full text

Medicine, Oncology, Pharmacotherapy +13